CSIMarket Company Name, Ticker, Industry, else..


Phoenix Biotech Acquisition Corp  (NASDAQ: PBAXU)
Other Ticker:  
 

Phoenix Biotech Acquisition Corp

PBAXU's Fundamental analysis



Phoenix Biotech Acquisition's sales fell in III. Quarter 2024 from the same quarter a year ago.

Biotechnology & Pharmaceuticals industry recorded growth of revenues by 13.31 %

Phoenix Biotech Acquisition net loss increased from $-1 millions, to $-4 millions in III. Quarter 2024,

• More on PBAXU's Growth


Phoenix Biotech Acquisition
realized a net loss in trailing twelve months.

Phoenix Biotech Acquisition realized cash reduction of $ -0.01 per share in trailing twelve-month period.
Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months.
Company
-
PE TTM   
Industry
-
PE TTM    
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.63.


• More on PBAXU's Valuation
 
 Total Debt (Millions $) 0
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) -
 Tangible Book Value (Per Share $) -0.10

Phoenix Biotech Acquisition
realized net loss in trailing twelve months.

Phoenix Biotech Acquisition realized cash outflow of $ -0.01per share in trailing twelve-month period.
Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months.
Company
-
PE TTM   
Industry
-
PE TTM    
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.63.


• More on PBAXU's Valuation

•  Market Capitalization (Millions $) 515
•  Shares Outstanding (Millions) 50
•  Employees -
•  Revenues (TTM) (Millions $) -
•  Net Income (TTM) (Millions $) -9
•  Cash Flow (TTM) (Millions $) -
•  Capital Exp. (TTM) (Millions $) -
•  Total Debt (Millions $) 0
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ -
•  Net Income/Employee(TTM) $ -
•  Receivable Turnover Ratio (TTM) -
•  Tangible Book Value (Per Share $) -0.10

•  Market Capitalization (Millions $) 515
•  Shares Outstanding (Millions) 50
•  Employees -
•  Revenues (TTM) (Millions $) -
•  Net Income (TTM) (Millions $) -9
•  Cash Flow (TTM) (Millions $) -
•  Capital Exp. (TTM) (Millions $) -





  Ratio
•   Capital Ratio (MRQ) 0.39
•  Total Debt to Equity (MRQ) -
•  Tangible Leverage Ratio (MRQ) -
•  Asset Turnover Ratio (TTM) -
•  Inventory Turnover Ratio (TTM) -





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com